Ehst, B.; Han, G.; Guenthner, S.; Eads, K.; Jacobson, A. Long-Term Efficacy and Safety of Brodalumab in Patients With Psoriasis Disease Duration ≪10 and ≥10 Years: Analysis of Two Phase 3 Studies. J of Skin 2019, 3, S25.